DIA 2020 Virtual Global Annual Meeting has ended

Create Your Own Event

DIA 2020 Virtual Global Annual Meeting

arrow_back View All Dates

8:00am EDT

#201 L: Patient-Centricity: How do We Measure Progress in Involving Patients in Drug Development and Drug Safety? TBD #202 L: Novel Approaches to Study Prevalent Chronic Diseases as Alternatives to Large-Scale Clinical Trials TBD #203 L: ICH 30th Anniversary Series: The Role of Multidisciplinary Topics TBD #204 L: Implementing Quality by Design for Clinical Trials: New Tools, Case Studies, and Multi-Stakeholder Discussion TBD #205 SL: Using Artificial Intelligence to Inform Regulatory and Development Strategies TBD #206 L: Regulatory Agility During the COVID-19 Pandemic TBD

9:00am EDT

#208.1 SL-IT: IBM Innovation Theater: New Ways to Apply Decentralized Trials During Covid-19 TBD #208.2 SL-IT: Covance Innovation Theater: Managing Complexity: The COVID-19 Road To Recovery and Restoration TBD

9:30am EDT

#209 L: Data Driven Monitoring Enabled Through Analytics and Quality Risk Management TBD #210 SL: Clinical Electronic Structured Harmonized Protocol (CeSHarP): ICH M11 - Status Update TBD #211 L: Balancing Clinical Trial Disclosure and Transparency With Global Data Protection Regulations TBD #212 L: Qualitative, Quantitative, and Mixed Method Approaches to Capture the Patient Experience TBD #213 L: Project Management in Times of Crisis TBD #214 L: GCP Quality and Compliance: The Regulators’ Perspective TBD #215 L: ACTIV: A Public-Private Partnership to Speed COVID-19 Therapies and Vaccines TBD

10:45am EDT

#217 SL-IT: ArisGlobal Innovation Theater: The Evolving Role of CTMS in Risk Management TBD #218 SL-IT: Veeva Innovation Theater: The Next Big Step Toward a Collaborative Clinical Ecosystem TBD #219 SL-IT: Google Innovation Theater: Next Generation Biomedical and Clinical Research Platform with Google Cloud and Deloitte TBD #216 L-RT: Round Table Discussion: Patient-Centricity: How Do We Measure Progress in Involving Patients in Drug Development and Drug Safety? TBD

11:30am EDT

#220 L: Disruptive Transformation in Safety Organizations TBD #221 L: Non-Traditional Clinical Trials Require a Non-Traditional Workforce TBD #222 L: Patient-Centricity: How Do We Talk to and Listen to Patients? TBD #223 L: Next Generation Analytics: Harnessing the Power of Nonclinical SEND Datasets to Improve Success in Early Clinical Development TBD #224 SL: Sponsor and Regulator Challenges, Risks, and Mitigation Strategies for Ensuring Third-Party Oversight of Vendors: Is Your Study Data at Risk? TBD #225 L: Accelerated Approval and Emerging Surrogate Endpoints TBD

12:30pm EDT

#609 NL: Networking Lounge: Real World Evidence TBD #610 NL: Networking Lounge: COVID-19 TBD #611 NL: Networking Lounge: Patient Focused TBD #612 NL: Networking Lounge: Emerging Professionals and Students TBD #613 NL: Networking Lounge: Digital Technology and Artifical Intelligence TBD #614 NL: Networking Lounge: Advanced Therapies TBD #615 NL: Networking Lounge: Data Science TBD #616 NL: Networking Lounge: Diversity, Disparities, and Inclusiveness TBD

12:45pm EDT

#226 SL-IT: Intersystems Innovation Theater: Investing in Real-Time, Real World Data to Accelerate Clinical Trials and Enhance Market Access TBD #228 SL-IT: Bioclinica Innovation Theater: Rescuing Clinical Adjudication Studies - Special Considerations When Transitioning From an Under-Performing Adjudication Provider TBD

1:15pm EDT

#229 L-RT: Round Table Discussion: RIM Working Group Update TBD

1:30pm EDT

#230 SL-CH: Staying Connected in a Virtual World: Communications Stakeholder Engagement That Drive Results TBD

1:40pm EDT

#230.2 SL-IT: ConvergeHEALTH by Deloitte Innovation Theater: The Future of Clinical Trials is Now- How Can Digital Transformation Enable More Seamless Recruitment, Increase Patient Engagement, and Improve Adherence... TBD

2:00pm EDT

#233 L: Practical Considerations for Robust Evaluation of Risk Minimization Programs: Regulatory, Industry, and Service Provider Insights TBD #234 SL: Practical Solutions for Designing and Conducting a Digital Health Trial TBD #235 SL: Examining Diversity in Clinical Trials TBD #236 L: FDA Data Standards Update TBD #237 L: Patient Voice and Its Role In Bringing Meaningfulness into Selection of Clinical Outcome Measures TBD #238 SL: Utilizing Cloud-Based Platforms in Regulatory Contexts TBD #239 L: The FDA Complex Innovative Trial Design Pilot Program: Case Examples TBD

3:15pm EDT

#241 SL-CH: A Risk-Based Approach to Implement Audit Trail Review and Inspection Readiness Plans in a Data Integrity Conscious World TBD #240 L-SB: On the Soapbox: At a Time of High Priced Medicines and a Global Pandemic - How Do We Make Medicines Accessible and Affordable to All? TBD #244 SL-IT: Veeva Innovation Theater: It's Time to Rethink Your EDC TBD #245 SL-IT: Parexel and Microsoft Innovation Theater: #KeepingPatientsFirst - An Integrated Research Platform for COVID-19 TBD #242 L-RT: Round Table Discussion: Examining Diversity in Clinical Trials TBD

4:00pm EDT

#246 SL: FDA Pre-Market Safety Assessment Program TBD #247 SL: Engaging Caregivers in Research and Medical Product Development TBD #248 L: Incorporating the Patient Perspective in a Drug Development Program TBD #249 L: Dynamic Multi-Disciplinary Collaboration for Aggregate Product Safety Assessment and Benefit-Risk Planning TBD #250 L: Projecting a Voice of Confidence in a World of Uncertainty TBD